NCT01855763 Metformin Treatment in Gestational Diabetes and Noninsulin Dependent Diabetes in Pregnancy in a Developing Country Status UNKNOWN Phase PHASE2/PHASE3
NCT01842620 OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. Status COMPLETED Phase PHASE4
NCT01834274 Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 Diabetes Status TERMINATED Phase PHASE3
NCT01825798 Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD) Status COMPLETED Phase PHASE3
NCT01822548 Effect of Vildagliptin vs. Glibenclamide on Circulating Endothelial Progenitor Cell Number Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01814748 A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028) Status COMPLETED Phase PHASE3
NCT01813929 Effect of Metformin on Vascular and Mitochondrial Function in Type 1 Diabetes Status COMPLETED Phase PHASE4
NCT01811953 Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered Together Status COMPLETED Phase PHASE1
NCT01808690 EMERALD: Effects of Metformin on Cardiovascular Function in Adolescents With Type 1 Diabetes Status COMPLETED Phase PHASE3
NCT01804049 Metformin and Muscle in Insulin-resistant Older Veterans Status COMPLETED Phase PHASE1/PHASE2
NCT01799057 The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication Status TERMINATED Phase PHASE4
NCT01797523 A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma Status COMPLETED Phase PHASE2
NCT01796028 Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancer Status COMPLETED Phase PHASE2
NCT01792830 Efficacy and Safety of a Glargine-based Hospital Discharge Algorithm in Coronary Artery Bypass Graft (CABG) Patients Status COMPLETED Phase PHASE3
NCT01787396 Phase III Trial to Evaluate the Efficacy and Safety of Initial Combination Therapy With Gemigliptin 50mg q.d and Metformin q.d Status COMPLETED Phase PHASE3
NCT01786707 Autologous Stem Cell and Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1/PHASE2
NCT01778244 Metformin for Treatment of Antipsychotic-induced Dyslipidemia Status COMPLETED Phase PHASE4